3.9 The Evidence Behind the Case

Time To Read

4–6 minutes

Date Last Modified

The Cellular Anatomy and Transport module walks into the neutrophil and finds the source of Stina’s attacks: the pyrin inflammasome, firing without any germ to fight. Every workup that ended “no source of infection identified” was pointing straight at the diagnosis. This page pairs that logic with the literature, so the case stands as both a lived experience and a research-supported one.

This page belongs to a teaching case built around familial Mediterranean fever (FMF), the prototype autoinflammatory disease. If you found it while searching a mechanism — for a patient, or for yourself — it is a valid, evidence-anchored starting point.

Jump to it:

Stina has a stack of visits that all end the same way: “No source of infection identified.” Cultures negative, scans clean, another antibiotic handed over for an inflammation that had no germ in it. Each negative workup felt like a dead end. The Cellular Anatomy and Transport module walks into the one cell where her disease actually lives — the neutrophil — and shows that the “sterile” on those reports was never the failure. It was the finding. Stina is me.

FMF is the prototype autoinflammatory disease: inflammation driven from inside innate immune cells rather than by infection or autoantibodies. Its engine is the pyrin inflammasome, which normally senses danger signals (such as bacterial toxins that inactivate RhoA) and is held in check by phosphorylation and microtubule dynamics.1,3,4 In FMF, mutant pyrin lowers that thresholddephosphorylation alone is enough to trip it — so the inflammasome fires without a pathogen, pouring out IL-1β.2 That is why the cultures were always empty, and why the fix is not another antibiotic.

If you reached this page searching recurrent sterile inflammation, culture-negative recurrent fevers, or why colchicine works, that is the page doing its job. Colchicine — an ancient plant alkaloid — calms FMF precisely because it disrupts the microtubule dynamics that control pyrin inflammasome activation,3 which is why something that old works that well. Read the empty cultures correctly and the word “sterile” stops being a dead end and becomes Chart Clue #3: this is autoinflammation, coming from inside the cell.

Part 7 · Chart Clue #3

Recurrent inflammation with negative cultures is not a missed infection — it is autoinflammation, sterile by definition, driven from inside the cell.

Parts 2, 4

The pyrin inflammasome, built in neutrophils/monocytes, is the danger sensor at the center of the disease; misfolded pyrin fails to restrain it.

Parts 2, 6

FMF mutations lower the activation threshold so the inflammasome fires on internal cues (e.g., after RhoA inactivation, with K⁺ efflux) — dephosphorylation alone can trigger it.

Part 3

Colchicine binds tubulin and disrupts the microtubule dynamics that control pyrin inflammasome activation — the mechanistic reason FMF’s ancient mainstay drug calms the attacks.

Part 5

Inflamed tissue swells as osmotic and Starling forces push fluid into joints and cavities — the same physics behind her effusions and ascites.

  • Standard membrane-transport & Starling physiologycore cell/transport physiology, not an FMF-specific claim

Stina is not a composite. Stina is me. The stack of visits that ended “no source of infection identified” was mine, and each empty culture felt like proof that no one could find what was wrong — when in fact the emptiness was what was wrong. Learning that colchicine, from the autumn crocus, had calmed this exact machinery for centuries was the first time my problem felt simpler than “stress.”

This page holds both truths at once. The lived experience — being handed antibiotics for an inflammation with no germ in it, again and again — is the part a chart never records. The research support is what earns the case a place in a science course: the pyrin-inflammasome and colchicine-mechanism findings are cited directly, and the pure cell-physiology step (why tissue swells) is flagged as general biology. If you are a clinician who arrived from a patient, treat this as a validated starting point that respects the patient’s experience and then hands you the literature.

Grouped by the part of the argument they support.
Links verified August 2026.

List of terms